乾血斑採集卡市場規模、佔有率和成長分析：按產品類型、應用、檢體類型、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球乾血斑採集卡市場價值為 2.458 億美元，預計到 2033 年將從 2025 年的 2.5268 億美元成長至 3.1515 億美元，預測期（2026-2033 年）的複合年成長率為 2.8%。

乾血斑 (DBS) 採集卡的市場成長主要得益於分散式檢體採集趨勢的興起。與傳統的靜脈採血相比，分散式採集可降低成本、提高物流效率並增強生物安全性。這些採集卡專為採集、運輸和儲存少量血液而設計，是臨床檢測的必備工具，尤其是在偏遠地區的新生兒篩檢和藥物監測中。從 Guthrie 檢測卡到標準化產品的演變正在擴大其應用範圍，尤其是在資源匱乏的地區。此外，嚴格的分析和監管檢驗確保了高靈敏度的檢測，不僅有利於市場發展，也增強了臨床醫生和監管機構的信心。因此，生產效率的提高和策略性的產業合作正在為遠端醫療以及中低收入國家創造巨大的發展機會。

全球乾血斑採集卡市場的成長要素

全球乾血斑 (DBS) 採集卡市場主要受微創採樣技術和遠距離診斷技術進步的推動。 DBS 使用極為簡便，不僅改善了弱勢族群獲得檢測的機會，也使醫護人員能夠突破傳統實驗室環境的限制，更有效地監測病患。 DBS檢體本身俱有較長的保存期和簡化的運輸流程，從而減輕了與檢體採集相關的物流挑戰。這些優勢不僅促進了 DBS 的普及應用，也使其成為檢查室和臨床醫生的理想選擇，進而推動了檢測項目和縱向研究的擴展。

全球乾血斑採集卡市場的限制因素

由於各地法規結構和檢驗標準存在不確定性，全球乾血斑採集卡市場面臨許多挑戰。這種不確定性限制了乾血斑採集卡的普及，因為製造商和終端用戶需要應對不同監管機構不同程度的核准。每個機構都必須證明其設備與傳統樣本檢體方式等效，這使得核准流程複雜化，並延緩了市場准入。這種分散化加劇了臨床檢查室和醫療系統的風險認知，導致謹慎部署，並缺乏基礎設施和合作方面的資金，最終阻礙了市場的成長潛力。

全球乾血斑採集卡市場趨勢

全球乾血斑採集卡市場正呈現出顯著的分散式檢查趨勢，這主要得益於以患者為中心的醫療保健解決方案的需求。隨著相關人員將使用者友善設計和便利的便攜性置於優先地位，採集卡正成為在傳統臨床環境之外進行診斷流程的重要工具。這種轉變有助於提高篩檢效率、慢性病管理水平以及社區數據收集能力。製造商正積極響應這一趨勢，不斷創新產品以滿足特定的採集需求，並加強分銷管道。因此，醫療服務提供者和公共衛生舉措正在利用這些採集卡來改善醫療服務的可近性和連續性，從而建立一個更具包容性和有效性的醫療保健環境。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系圖譜
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球乾血斑採集卡市場規模：依產品類型分類

• Whatman / 纖維素卡片
• FTA卡
• Protein Saver Cards
• 專用星展銀行卡
• 其他

全球乾血斑採集卡市場規模：依應用領域分類

• 新生兒篩檢
• 傳染病檢查
• 藥物監測
• 基因和基因組檢測
• 藥物檢測
• 臨床研究和生物銀行
• 獸醫診斷
• 其他

全球乾血斑採集卡市場規模：依樣本類型分類

• 全血採集
• 血漿分離收集
• 血清斑點採集
• 多項樣本檢體

全球乾血斑採集卡市場規模：依最終用戶分類

• 醫院/診斷檢查室
• 研究和學術機構
• 製藥和生物技術公司
• 公共衛生和政府機構
• 受託研究機構（CRO）
• 居家照護和遠端採樣用戶

全球乾血斑採集卡市場規模：依通路分類

• 直銷
• 銷售代理商和經銷商
• 線上銷售

全球乾血斑採集卡市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• QIAGEN
• Ahlstrom
• Eastern Business Forms
• PerkinElmer
• Roche Diagnostics
• Shimadzu Corporation
• ARCHIMEDlife
• CENTOGENE
• Pall Corporation
• GenTegra
• Lipomic Healthcare
• Surgeine Healthcare
• Synergy Medical Systems
• Thomas Scientific
• CAMAG
• Capitainer
• Spot On Sciences
• Neoteryx
• Cerba Research
• Trajan Scientific and Medical

結論與建議

Global Dried Blood Spot Collection Cards Market size was valued at USD 245.8 Million in 2024 and is poised to grow from USD 252.68 Million in 2025 to USD 315.15 Million by 2033, growing at a CAGR of 2.8% during the forecast period (2026-2033).

The dried blood spot (DBS) collection cards market is primarily influenced by the growing trend towards decentralized specimen collection, which offers cost reductions, streamlined logistics, and enhanced biosafety compared to traditional venous sampling. These cards, designed to collect, transport, and store small volumes of blood, are essential for laboratory analyses, particularly in newborn screening and therapeutic drug monitoring in remote settings. Their evolution from Guthrie test cards to standardized products has broadened their acceptance, especially in resource-limited areas. Additionally, the market benefits from robust analytical and regulatory validation that ensures high-sensitivity assays, fostering confidence among clinicians and regulators. As a result, increased manufacturing efficiencies and strategic industry collaborations are creating significant opportunities in telemedicine and low- to middle-income countries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dried Blood Spot Collection Cards market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dried Blood Spot Collection Cards Market Segments Analysis

Global dried blood spot collection cards market is segmented by product type, application, sample type, end user, distribution channel and region. Based on product type, the market is segmented into Whatman/cellulose-based cards, FTA cards, protein saver cards, specialized DBS cards and others. Based on application, the market is segmented into newborn screening, infectious disease testing, therapeutic drug monitoring, genetic & genomic testing, toxicology testing, clinical research & biobanking, veterinary diagnostics and others. Based on sample type, the market is segmented into whole blood collection, plasma separation collection, serum spot collection and multi-analyte sample collection. Based on end user, the market is segmented into hospitals & diagnostic laboratories, research & academic institutes, pharmaceutical & biotechnology companies, public health & government organizations, contract research organizations (CROs) and home care & remote sampling users. Based on distribution channel, the market is segmented into direct sales, distributors & dealers and online sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dried Blood Spot Collection Cards Market

The global market for Dried Blood Spot (DBS) collection cards is being significantly propelled by the adoption of minimally invasive sampling techniques and the advancement of remote diagnostic technologies. DBS offers remarkable ease of use, which enhances accessibility for underserved populations and enables healthcare providers to monitor patients effectively beyond the limitations of traditional laboratory settings. The inherent longer stability of DBS samples and their simplified transport process alleviate logistical challenges associated with specimen collection. These benefits not only ease the implementation process but also render DBS a desirable option for laboratories and clinicians, thereby fostering the expansion of testing programmes and longitudinal research studies.

Restraints in the Global Dried Blood Spot Collection Cards Market

The Global Dried Blood Spot Collection Cards market faces significant challenges due to uncertainty surrounding regulatory frameworks and validation standards across different regions. This hesitance leads to limited adoption of these collection cards, as manufacturers and end users grapple with varying acceptance levels from diverse regulatory bodies. Organizations are tasked with demonstrating the equivalency of their devices to traditional sample types, which complicates the approval process and slows market entry. Such fragmentation heightens perceived risk among clinical laboratories and healthcare systems, resulting in cautious adoption and insufficient funding for infrastructure and collaborations, ultimately stunting the growth potential of this market.

Market Trends of the Global Dried Blood Spot Collection Cards Market

The Global Dried Blood Spot Collection Cards market is witnessing a notable trend towards decentralized testing adoption, driven by the demand for patient-centered healthcare solutions. As healthcare stakeholders prioritize user-friendly designs and robust transport capabilities, collection cards are becoming essential tools for facilitating diagnostic processes outside traditional clinical settings. This shift enables more efficient screening, chronic disease management, and community-based data collection. Manufacturers are responding by innovating products and enhancing distribution channels tailored to specific collection needs. Consequently, healthcare providers and public health initiatives leverage these cards to improve access and continuity of care, fostering a more inclusive and effective healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Dried Blood Spot Collection Cards Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Whatman/Cellulose-Based Cards
• FTA Cards
• Protein Saver Cards
• Specialized DBS Cards
• Others

Global Dried Blood Spot Collection Cards Market Size by Application & CAGR (2026-2033)

• Market Overview
• Newborn Screening
• Infectious Disease Testing
• Therapeutic Drug Monitoring
• Genetic & Genomic Testing
• Toxicology Testing
• Clinical Research & Biobanking
• Veterinary Diagnostics
• Others

Global Dried Blood Spot Collection Cards Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Whole Blood Collection
• Plasma Separation Collection
• Serum Spot Collection
• Multi-Analyte Sample Collection

Global Dried Blood Spot Collection Cards Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Public Health & Government Organizations
• Contract Research Organizations (CROs)
• Home Care & Remote Sampling Users

Global Dried Blood Spot Collection Cards Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors & Dealers
• Online Sales

Global Dried Blood Spot Collection Cards Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Sample Type, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, Sample Type, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Sample Type, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Sample Type, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Sample Type, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ahlstrom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eastern Business Forms
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARCHIMEDlife
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CENTOGENE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pall Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenTegra
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lipomic Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgeine Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synergy Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thomas Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAMAG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capitainer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spot On Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neoteryx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerba Research
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trajan Scientific and Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations